严重烧伤合并ARDS患者V-V ECMO预后预测因素及纵向动态的单中心队列研究
ECMO成功脱机率56.3%,30天和60天生存率均为50%,一年生存率33.3%。非生存者烧伤更重、ECMO启动时生理紊乱更明显,且乳酸持续升高、PaCO₂更高、pH更低。
要点
- 严重烧伤合并ARDS接受V-V ECMO者死亡率高,一年生存率仅33.3%。
- 非生存者TBSA更大、全层烧伤更多、ABSI和修订Baux评分更高。
- ECMO启动时SOFA评分、乳酸及凝血异常更高提示预后不良。
核心结论
- V-V ECMO是部分严重烧伤合并ARDS患者的可行挽救策略,但死亡率仍高,且死亡主要由烧伤特异性和全身性因素驱动,而非单纯呼吸衰竭。
主要发现
- ECMO成功脱机率为56.3%,ECMO启动后30天和60天生存率均为50%,一年生存率为33.3%。
- 非生存者烧伤更严重,表现为TBSA更高、全层烧伤更多、ABSI和修订Baux评分更高。
- 非生存者ECMO启动时SOFA评分更高、乳酸水平更高且凝血异常更明显。
- RESP评分区分能力有限;两组血流量和扫气流量相当,但非生存者乳酸持续升高、PaCO₂更高、pH更低,氧合维持。
临床怎么用
- 对严重烧伤合并ARDS患者,V-V ECMO可作为挽救治疗,但需结合烧伤严重度标志物和早期生理轨迹评估预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a major complication in severely burn-injured patients and is associated with high mortality. In refractory respiratory failure, veno-venous extracorporeal membrane oxygenation (V-V ECMO) may serve as rescue therapy. However, evidence in burn-injured patients remains limited, and burn-specific predictors of outcome are poorly defined. METHODS: This retrospective single-center cohort study included all severely burn-injured patients with ARDS treated with V-V ECMO between January 2022 and October 2025. Survivors and non-survivors were compared regarding burn characteristics, clinical course, ECMO-related parameters, and complications. Longitudinal physiological and ECMO-specific parameters, including blood flow, sweep gas flow, lactate, and gas exchange variables, were analyzed. RESULTS: Sixteen patients were included. Successful ECMO weaning was achieved in 56.3%. Survival at 30 and 60 days after ECMO initiation was 50%, while one-year survival was 33.3%. Non-survivors showed greater burn severity, reflected by higher total body surface area (TBSA), more full-thickness burns, and higher abbreviated burn severity index (ABSI) and revised Baux scores. At ECMO initiation, they exhibited greater physiological derangement, including higher sequential organ failure assessment scores (SOFA), lactate levels, and coagulation abnormalities. The respiratory ECMO survival prediction score (RESP) showed limited discriminatory value. Blood flow and sweep gas flow were comparable between groups, whereas non-survivors demonstrated persistently elevated lactate levels, higher PaCO₂, and lower pH despite maintained oxygenation. CONCLUSIONS: V-V ECMO is a feasible rescue strategy in selected severely burn-injured patients with ARDS, but mortality remains high and appears to be driven predominantly by burn-specific and systemic factors rather than respiratory failure alone. Burn severity markers and early physiological trajectories may provide valuable prognostic information.
引用
- Macedo Santos E, Schmidt SV, Buchwald D, et al. Veno-venous extracorporeal membrane oxygenation (V-V ECMO) for acute respiratory distress syndrome (ARDS) in severely burn-injured patients: A single-center cohort study of outcome predictors and longitudinal ECMO dynamics. Burns. 2026. PMID: 42868689. doi:10.1016/j.burns.2026.108199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。